Summary

Respiratory diseases are a significant health concern in the Middle East and Africa, including chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections, are major public health concerns across the Middle East and Africa. A lack of proper healthcare facilities, smoking, and air pollution all frequently make these diseases worse. Government support for the respiratory care devices industry in the Middle East and Africa region is varied. Some countries, such as Saudi Arabia and the United Arab Emirates, have significant government investment in the sector including, the Saudi Food and Drug Authority (SFDA), it regulates medical devices in Saudi Arabia. The SFDA ensures the safety, efficacy, and quality of medical devices. Middle East respiratory syndrome (MERS) is a viral respiratory infection that is caused by a coronavirus called Middle East respiratory syndrome coronavirus (MERS-CoV). Humans are infected with MERS-CoV from direct or indirect contact with dromedary camels who are the natural host and zoonotic source of the MERS-CoV infection. The MERS-CoV outbreak has highlighted the need for improved respiratory care capacity in the MEA region. Furthermore, national and regional organizations that promote respiratory health, such as the Middle East and North Africa (MENA) Thoracic Society, puts in great effort to increase public knowledge of respiratory illnesses. To advance best practices in diagnosis and treatment, they lead research projects, arrange conferences, and run teaching programs. Additionally, in order to provide patients with the resources they require to properly manage their diseases, these associations support increased access to respiratory care devices and therapies.

According to the research report, “Middle East and Africa Respiratory Care Devices Market Outlook, 2028” published by Bonafide Research, the market anticipated to reach more than USD 2 Billion by 2028. The respiratory monitoring device market in the MEA is expected to continue to grow in the coming years. Patients with respiratory diseases are increasingly demanding home and remote monitoring solutions. This is due to a number of factors, including the convenience of being able to monitor their condition from home, the ability to reduce their hospital visits, and the desire to have more control over their care. There have been a number of technological advancements in recent years that have made respiratory monitoring devices more affordable, accurate, and user-friendly. This has made these devices more accessible to a wider range of patients. In addition to the factors mentioned above, the COVID-19 pandemic has also had a significant impact on the respiratory monitoring device market in the UAE. The pandemic has led to an increased demand for respiratory monitoring devices, both in hospitals and in homes. Regional R&D efforts frequently result in the development of cutting-edge equipment and therapies that benefit both local and global populations. While major metropolitan regions have excellent medical facilities, rural communities may have limited access to healthcare. As a result, the availability and utilization of respiratory care devices is increasing in these rural areas. Many companies and the government support are also expanding their presence thus contributing to the overall growth of the market.

In the Middle East and Africa region, the respiratory care devices market is segmented into various countries, with key players including the United Arab Emirates (UAE), Saudi Arabia, and South Africa. Among these nations, Saudi Arabia emerges as a dominant force in the market. The Kingdom of Saudi Arabia boasts a rapidly growing healthcare sector and is investing heavily in medical equipment and technologies, including respiratory care devices. The country's commitment to advancing its healthcare infrastructure and addressing respiratory health concerns positions it as a leader in the market. South Africa is another prominent player in the region, with a growing emphasis on medical equipment and technology. The country's healthcare industry is evolving, and the demand for respiratory care devices is on the rise. South Africa's focus on improving healthcare accessibility and quality has contributed to its significant market share in the respiratory care segment. The United Arab Emirates (UAE) also holds a noteworthy share in the market. The UAE's strategic location and robust economy have led to substantial investments in healthcare, including respiratory care equipment. The country's commitment to innovation and medical excellence ensures that it remains a key player in the regional market.

The market for respiratory care equipment in the Middle East and Africa is exhibiting a fascinating trend in product segmentation, featuring categories such as therapeutic devices, diagnostic devices, monitoring devices, and consumables and accessories. Among these categories, the fastest growth is anticipated for consumables and accessories. This growth trajectory is a reflection of the changing healthcare environment in the area. A vast array of respiratory care items, including filters, masks, tubing, and other disposables necessary for the upkeep and functioning of respiratory devices including ventilators, CPAP machines, and nebulizers, are included in the category of consumables and accessories. In the segmentation of disease indications within the respiratory equipment market in the Middle East and Africa, Chronic Obstructive Pulmonary Disease (COPD) emerges as the central player, commanding a substantial market share due to its high prevalence in the region. COPD, a progressive lung disease often linked to smoking and environmental factors, requires a comprehensive range of therapeutic devices for management. The demand for COPD-specific respiratory equipment, such as nebulizers, inhalers, and oxygen therapy systems, remains notably high to address the symptoms and complications associated with this condition. Following COPD, sleep apnea and asthma also claim significant portions of the market share. Sleep apnea, characterized by interrupted breathing during sleep, necessitates specialized respiratory devices like continuous positive airway pressure (CPAP) machines. These devices aid in maintaining open airways, providing effective therapy for sleep-disordered breathing, contributing substantially to the market. Similarly, asthma, a prevalent chronic respiratory condition, drives the demand for inhalers, nebulizers, and various respiratory aids. Additionally, infectious diseases, particularly those affecting the respiratory system, also significantly contribute to the market share, especially considering recent global health challenges. The emphasis on diagnosis and management of infectious respiratory diseases, particularly in the context of the COVID-19 pandemic, has led to an increased demand for diagnostic and monitoring devices, ventilators, and other specialized equipment, underscoring their significance within the overall market. This diverse landscape of disease indications within the Middle East and Africa's respiratory equipment market highlights the importance of tailored and diversified respiratory devices in addressing the multifaceted healthcare needs stemming from various respiratory conditions prevalent in the region.

Within the respiratory equipment market in the Middle East and Africa, the segmentation according to end users reflects the diversified landscape of healthcare provision in the region. Hospitals play a fundamental and dominating role in providing respiratory care, characterized by their extensive infrastructure, specialized medical personnel, and immediate access to a wide array of respiratory devices. These institutions serve as the primary and critical centers for acute and severe respiratory cases, offering immediate and intensive care to patients. Ambulatory Care Centers (ACCs) also hold a significant presence in the market, contributing as key players in providing outpatient respiratory care. ACCs focus on delivering specialized services for patients requiring ongoing monitoring and diagnosis, but not necessarily the intense interventions provided by hospitals. Moreover, home care settings are emerging as a progressively influential segment in the market, driven by the growing emphasis on patient-centric care, technological advancements, and the preference for personalized care in the comfort of one's home. The shift towards home care solutions, particularly for chronic respiratory conditions like COPD and sleep apnea, anticipates a notable market share in the near future. This trend aims to enhance patient comfort, reduce healthcare costs, and offer convenient and personalized care options. The category of "other end users" encapsulates various healthcare facilities and providers, collectively contributing to the multifaceted approach in addressing respiratory care in the Middle East and Africa. This comprehensive segmentation highlights the diverse approaches and the evolving dynamics within the respiratory equipment market, indicating the market's adaptability to cater to the varied needs of patients across different healthcare settings in the region.

Companies Covered in this report:
Koninklijke Philips N.V., Medtronic Inc, Masimo Corporation, Cardinal Health, Inc, Medline Industries, Baxter International Inc., Stryker Corporation, Siemens AG , Dragerwerk AG & Co. KGaA, Nidek Medical products Inc., Besco Medical Limited.

Considered in this report:
• Geography: Middle East and Africa
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Middle East and Africa Respiratory Care Devices market Outlook with its value and forecast along with its segments
• Country-wise Respiratory Care Devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:
• United Arab Emirates (UAE)
• Saudi Arabia
• South Africa

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.




***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents